pralnacasan has been researched along with Colitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, C; Dauer, M; Eigler, A; Endres, S; Landauer, N; Lehr, HA; Loher, F; Schmall, K; Schoenharting, M; Siegmund, B | 1 |
Bauer, C; Dauer, M; Eigler, A; Endres, S; Hallwachs, R; Lehr, HA; Loher, F; Mayer, C; Schönharting, M | 1 |
2 other study(ies) available for pralnacasan and Colitis
Article | Year |
---|---|
The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Topics: Animals; Azepines; Caspase Inhibitors; Colitis; Colon; Dextran Sulfate; Drug Interactions; Female; Interferon-gamma; Interleukin-1; Interleukin-18; Isoquinolines; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Para-Aortic Bodies; Pyridazines; Spleen; T-Lymphocytes, Helper-Inducer | 2004 |
The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression.
Topics: Animals; Azepines; Caspase 1; Caspase Inhibitors; Chemokine CCL2; Chemokine CXCL1; Chemokine CXCL10; Chemokines, CXC; Colitis; Colon; Dextran Sulfate; Epithelium; Female; Interferon-gamma; Interleukin-18; Isoquinolines; Mice; Mice, Inbred C57BL; Pyridazines; RNA, Messenger; Th1 Cells; Tumor Necrosis Factor-alpha | 2007 |